Why Viagra Stopped Working, And What to Do About It

By Dr. Meyer Schoeman, MD — Precision Sexual Health Clinic, Calgary

You were prescribed sildenafil or tadalafil. It worked well initially. Then gradually (or sometimes suddenly) it stopped delivering the same results. For men struggling with erectile dysfunction, this can be frustrating and confusing. The erections became less reliable, less rigid, or stopped responding altogether.

This is more common than most men realise. And it’s not simply because the medication “wore off.” There are specific, identifiable reasons why PDE-5 inhibitors lose efficacy over time, and most of them point toward something that needs to be addressed clinically, not just managed with a higher dose.

Why PDE-5 Inhibitors Stop Working

PDE-5 inhibitors potentiate the nitric oxide pathway by blocking phosphodiesterase type 5, the enzyme that degrades cyclic GMP in penile smooth muscle. The result is enhanced smooth muscle relaxation, increased arterial inflow, and improved erection. But this mechanism depends entirely on an intact nitric oxide signal to begin with. If endothelial function deteriorates — because of progressive atherosclerosis, worsening metabolic syndrome, uncontrolled hypertension, or diabetes — there is less nitric oxide to potentiate. The drug has less substrate to work with, and its effect diminishes accordingly.

Testosterone decline is a frequently overlooked contributor. Testosterone supports penile tissue health, including smooth muscle integrity and nitric oxide synthase expression. A man whose testosterone has fallen significantly since his PDE-5 inhibitor was first prescribed may find the medication less effective not because of the drug, but because the androgen environment supporting the erectile mechanism has deteriorated. Checking testosterone when PDE-5 inhibitors lose efficacy is not optional , it’s basic clinical due diligence.

There are also adherence and administration factors that are commonly underappreciated. Sildenafil’s efficacy is significantly reduced when taken with a high-fat meal. It requires adequate sexual stimulation;  it is not an arousal drug. 

Timing also matters. Some men who report treatment failure are actually experiencing suboptimal administration rather than true pharmacological non-response.

True Non-Responders

While oral medications are widely considered first-line treatments, they are not universally effective. Clinical data shows that approximately 30% to 35% of men do not respond adequately to PDE-5 inhibitors, regardless of the dose or administration schedule. These are typically men with more advanced vasculogenic disease, post-radical prostatectomy neuropraxia, or significant cavernous fibrosis from untreated or longstanding ED. In these men, escalating the PDE-5 inhibitor dose is unlikely to produce meaningful improvement.

This is where second and third-line therapies become relevant. Intracavernosal injection therapy — most commonly Trimix (a combination of alprostadil, phentolamine, and papaverine) — bypasses the nitric oxide pathway entirely. It acts directly on cavernosal smooth muscle, producing reliable erections in men who have failed oral therapy, including many post-prostatectomy patients. The response rate is significantly higher than oral agents for true non-responders, and most men who are properly counselled find self-injection manageable and effective.

ED medication reassessment for men in Calgary Alberta Viagra stopped working consultation in Calgary Shockwave PRP and Trimix treatment options for Calgary men

Restorative Options

Low-Intensity Extracorporeal Shockwave Therapy is increasingly relevant for men with acquired PDE-5 inhibitor failure due to vasculogenic disease. By stimulating neovascularisation and improving cavernosal blood flow, it can restore responsiveness to oral therapy in men who have developed relative non-response. 

The evidence is strongest for men with mild-to-moderate vascular issues. In fact, a clinical review by Canada’s Drug Agency confirms that shockwave therapy significantly improves tissue hardness, helping many men regain a meaningful response to oral ED medications. 

PRP therapy — platelet-rich plasma injected into the corpus cavernosum — is an adjunctive option with a proposed mechanism involving growth factor release and tissue regeneration. The evidence is earlier-stage than for shockwave, but it is increasingly used as part of a combination approach for men with refractory vasculogenic ED.

The Right Response to Loss of Efficacy

When a PDE-5 inhibitor stops working, the response should not be to accept it as inevitable decline or to simply switch brands. It should be to investigate why. A proper re-evaluation — testosterone panel, cardiovascular risk assessment, review of comorbidities and medications, honest assessment of lifestyle factors — will almost always identify something addressable.

ED that doesn’t respond to oral therapy is not the end of the road. It is the beginning of a more specific clinical conversation. Take the first step and book a consultation at Precision Clinic Calgary today.

Dr. Meyer Schoeman is the founder of Precision Sexual Health Clinic for Men in Calgary. The clinic offers second and third-line ED treatments including shockwave therapy, PRP, and Trimix for men who have not responded to oral therapy. Book a consultation at precisioncliniccalgary.ca.